The Patent Finder

Revance Therapeutics, Inc.

Also on record
Records under this name other than the patents Revance Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 28 patents it holds.

Back to Revance Therapeutics, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 10,441,641Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect
Term ended
Term ended Jun 7, 2026 · High confidence
Term endedTerm ended Jun 7, 2026High confidence
US 9,180,081Compositions and Methods for Topical Application and Transdermal Delivery of Botulinum Toxins
Term ended
Term ended Mar 15, 2026 · High confidence
Term endedTerm ended Mar 15, 2026High confidence
US 9,314,416Compositions and Methods for Topical Application and Transdermal Delivery of Botulinum Toxins
Term ended
Term ended Mar 15, 2026 · High confidence
Term endedTerm ended Mar 15, 2026High confidence
US 10,080,786Methods for Treating Pain by Topical Application and Transdermal Delivery of Botulinum Toxin
Term ended
Ended no later than Mar 3, 2026 · Medium confidence
Term endedEnded no later than Mar 3, 2026Medium confidence
US 10,744,078Compositions and Methods for Topical Application and Transdermal Delivery of Botulinum Toxins
Term ended
Term ended Mar 3, 2026 · High confidence
Term endedTerm ended Mar 3, 2026High confidence
US 8,580,745Composition for therapeutic and cosmetic botulinum toxin
Lapsed on the fee record
Ended Nov 12, 2025 · Medium confidence
Lapsed on the fee recordEnded Nov 12, 2025Medium confidence
US 7,459,164Composition for Therapeutic and Cosmetic Botulinum Toxin
Term ended
Term ended Jul 5, 2025 · High confidence
Term endedTerm ended Jul 5, 2025High confidence
US 8,092,788Compositions and Methods for Topical Diagnostic and Therapeutic Transport
Term ended
Term ended Mar 3, 2025 · High confidence
Term endedTerm ended Mar 3, 2025High confidence
US 9,211,248Compositions and Methods for Topical Application and Transdermal Delivery of Botulinum Toxins
Term ended
Term ended Mar 3, 2025 · High confidence
Term endedTerm ended Mar 3, 2025High confidence
US 7,270,826Methods of Using Botulinum Toxin for the Treatment of Hypervolemic Lip Deformity (LIP Ectropion)
Term ended
Term ended Jan 5, 2025 · High confidence
Term endedTerm ended Jan 5, 2025High confidence
10 of 96 records shown.
Pro members see all 96.
Pro members: see all 96 records
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited